TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression

• Published in: Cell death & disease 2021-06, Vol.12 (7), p.642-13, Article 642
• Main Authors: Zhang, Xiang, Zhao, Song, Yuan, Qingqing, Zhu, Lin, Li, Fan, Wang, Hui, Kong, Dezhi, Hao, Jun
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; 13/2; 13/89; 13/95; 14/19; 14/28; 38/109; 38/47; 631/80/86/2367; 64/60; 692/699/2743/137/138; 692/699/375/430; 82/51; 82/80; 9/30; AKT protein; Animals; Antibodies; Apoptosis; Apoptosis Regulatory Proteins - metabolism; Autophagy; Autophagy-Related Proteins - metabolism; Bax protein; Biochemistry; Biomedical and Life Sciences; Blood Glucose - metabolism; Carrier Proteins - genetics; Carrier Proteins - metabolism; Caspase-3; Cell Biology; Cell Culture; Cell Cycle Proteins - genetics; Cell Cycle Proteins - metabolism; Cell Line; Diabetes; Diabetes mellitus; Diabetic Neuropathies - enzymology; Diabetic Neuropathies - genetics; Diabetic Neuropathies - pathology; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1 - genetics; DNA (Cytosine-5-)-Methyltransferase 1 - metabolism; DNA (Cytosine-5-)-Methyltransferases - genetics; DNA (Cytosine-5-)-Methyltransferases - metabolism; DNA methyltransferase; DNA Methyltransferase 3A; DNMT1 protein; Glucose; Humans; Immunology; Inflammation; Life Sciences; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin; Nerve conduction; Oxidative stress; Peripheral neuropathy; Phagocytosis; Phosphatidylinositol 3-Kinase - metabolism; Proteins; Proto-Oncogene Proteins c-akt - metabolism; Rats; Schwann cells; Schwann Cells - enzymology; Schwann Cells - pathology; Sciatic Nerve - enzymology; Sciatic Nerve - pathology; Signal Transduction; Thioredoxin; Thioredoxins - genetics; Thioredoxins - metabolism
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-021-03930-2

Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus (DM) and the dysfunction of Schwann cells plays an important role in the pathogenesis of DPN. Thioredoxin-interacting protein (TXNIP) is known as an inhibitor of thioredoxin and associated with oxidative stress and inflammation. However, whether TXNIP is involved in dysfunction of Schwann cells of DPN and the exact mechanism is still not known. In this study, we first reported that TXNIP expression was significantly increased in the sciatic nerves of diabetic mice, accompanied by abnormal electrophysiological indexes and myelin sheath structure. Similarly, in vitro cultured Schwann cells TXNIP was evidently enhanced by high glucose stimulation. Again, the function experiment found that knockdown of TXNIP in high glucose-treated RSC96 cells led to a 4.12 times increase of LC3-II/LC3-I ratio and a 25.94% decrease of cleaved caspase 3/total caspase 3 ratio. Then, DNA methyltransferase (DNMT) inhibitor 5-Aza has been reported to benefit Schwann cell in DPN, and here 5-Aza treatment reduced TXNIP protein expression, improved autophagy and inhibited apoptosis in high glucose-treated RSC96 cells and the sciatic nerves of diabetic mice. Furthermore, DNMT1 and DNMT3a upregulation were found to be involved in TXNIP overexpression in high glucose-stimulated RSC96 cells. Silencing of DNMT1 and DNMT3a effectively reversed high glucose-enhanced TXNIP. Moreover, high glucose-inhibited PI3K/Akt pathway led to DNMT1, DNMT3a, and TXNIP upregulation in RSC96 cells. Knockdown of DNMT1 and DNMT3a prevented PI3K/Akt pathway inhibition-caused TXNIP upregulation in RSC96 cells. Finally, in vivo knockout of TXNIP improved nerve conduction function, increased autophagosome and LC3 expression, and decreased cleaved Caspase 3 and Bax expression in diabetic mice. Taken together, PI3K/Akt pathway inhibition mediated high glucose-induced DNMT1 and DNMT3a overexpression, leading to cell autophagy inhibition and apoptosis via TXNIP protein upregulation in Schwann cells of DPN.